α-protein kinase 2 Inhibitors encompass a diverse group of chemicals that are designed to modulate the activity or influence of the enzyme α-protein kinase 2 (ALPK2). Given the current understanding of ALPK2, there's no specific group of compounds that solely target it. Rather, the inhibition might be achieved indirectly by affecting pathways or processes that are linked or associated with its activity.
Compounds such as Staurosporine and H-89 can inhibit various protein kinases, thus influencing ALPK2's role in various cellular processes. By inhibiting other enzymes in the kinase family or pathways that may have connections to ALPK2's function, these compounds serve to dampen or regulate the enzyme's activity. Other molecules like LY294002 or PD98059 specifically target elements of the PI3K or MAPK/ERK pathways, respectively. Since these pathways are intricate webs of protein interactions and signaling cascades, their modulation can have an impact on numerous proteins, possibly including ALPK2.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A broad-spectrum protein kinase inhibitor that can inhibit various kinases, possibly affecting ALPK2 indirectly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, which might affect pathways involving ALPK2. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor, affecting the MAPK/ERK pathway that can potentially interact with ALPK2. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3K inhibitor that can impact pathways possibly connected to ALPK2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
P38 MAPK inhibitor, impacting signaling pathways that ALPK2 may participate in. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, potentially affecting cellular processes linked with ALPK2. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor that can influence cellular signaling that involves ALPK2. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
NF-κB pathway inhibitor that may have downstream effects on proteins like ALPK2. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $103.00 $293.00 $465.00 | 15 | |
Broad-spectrum PKC inhibitor which can indirectly influence ALPK2's activity or related pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Rho-associated protein kinase (ROCK) inhibitor that might influence processes involving ALPK2. | ||||||